Thrombocytopenia Clinical Trials in Jinan, Shandong
6 recruitingJinan, Shandong, China
Showing 1–6 of 6 trials
Recruiting
Phase 3
High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune Thrombocytopenia
Primary Immune Thrombocytopenia (ITP)
Shandong University86 enrolled1 locationNCT07559331
Recruiting
Phase 2
A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)
Immune Thrombocytopenia (ITP)
Dizal Pharmaceuticals60 enrolled1 locationNCT07294365
Recruiting
Phase 1Phase 2
A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia
Chronic Immune Thrombocytopenia
CASI Pharmaceuticals, Inc.75 enrolled6 locationsNCT07017725
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia
Immune Thrombocytopenia (ITP)
Shanghai Escugen Biotechnology Co., Ltd84 enrolled1 locationNCT06853444
Recruiting
Phase 2
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
ThrombocytopeniaConnective Tissue Diseases
Beijing Hospital296 enrolled23 locationsNCT05998759
Recruiting
Phase 3
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd.195 enrolled45 locationsNCT06004856